138 related articles for article (PubMed ID: 21584419)
1. Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica.
França TC; Griz L; Pinho J; Diniz ET; Andrade LD; Lucena CS; Beserra SR; Asano NM; Duarte AP; Bandeira F
Rev Bras Reumatol; 2011; 51(2):131-7. PubMed ID: 21584419
[TBL] [Abstract][Full Text] [Related]
2. Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome.
Davenport A; Stearns MP
Nephrology (Carlton); 2007 Aug; 12(4):386-90. PubMed ID: 17635755
[TBL] [Abstract][Full Text] [Related]
3. Postoperative calcium requirements in 6,000 patients undergoing outpatient parathyroidectomy: easily avoiding symptomatic hypocalcemia.
Vasher M; Goodman A; Politz D; Norman J
J Am Coll Surg; 2010 Jul; 211(1):49-54. PubMed ID: 20610248
[TBL] [Abstract][Full Text] [Related]
4. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy.
Agarwal G; Mishra SK; Kar DK; Singh AK; Arya V; Gupta SK; Mithal A
Surgery; 2002 Dec; 132(6):1075-83; discussion 1083-5. PubMed ID: 12490858
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
[TBL] [Abstract][Full Text] [Related]
6. [Changes in calcium metabolism after parathyroidectomy in primary hyperparathyroidism].
Berczi C; Balogh A; Balázs G; Lukács G
Orv Hetil; 2002 Mar; 143(12):597-600. PubMed ID: 11963396
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.
Lee IT; Sheu WH; Tu ST; Kuo SW; Pei D
J Bone Miner Metab; 2006; 24(3):255-8. PubMed ID: 16622740
[TBL] [Abstract][Full Text] [Related]
8. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
9. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management.
Mittendorf EA; Merlino JI; McHenry CR
Am Surg; 2004 Feb; 70(2):114-9; discussion 119-20. PubMed ID: 15011912
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of preoperative procollagen type 1 N-terminal peptide and collagen type 1 C-telopeptide levels in the prediction of postoperative hypocalcemia in patients undergoing parathyroidectomy due to primary hyperparathyroidism.
Martlı HF; Saylam B; Er S; Yücel Ç; Tez M
Langenbecks Arch Surg; 2023 Jan; 408(1):71. PubMed ID: 36720758
[TBL] [Abstract][Full Text] [Related]
11. Evolution of maxillofacial brown tumors after parathyroidectomy in primary hyperparathyroidism.
Reséndiz-Colosia JA; Rodríguez-Cuevas SA; Flores-Díaz R; Juan MH; Gallegos-Hernández JF; Barroso-Bravo S; Gómez-Acosta F
Head Neck; 2008 Nov; 30(11):1497-504. PubMed ID: 18704965
[TBL] [Abstract][Full Text] [Related]
12. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
13. Predictors of early postoperative hypocalcemia in hemodialysis patients with secondary hyperparathyroidism.
Torer N; Torun D; Torer N; Micozkadioglu H; Noyan T; Ozdemir FN; Haberal M
Transplant Proc; 2009 Nov; 41(9):3642-6. PubMed ID: 19917359
[TBL] [Abstract][Full Text] [Related]
14. [Anesthesia and postoperative recovery for parathyroid gland surgery].
Roland E
Ann Chir; 1999; 53(2):150-61. PubMed ID: 10089669
[TBL] [Abstract][Full Text] [Related]
15. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study.
Lumachi F; Camozzi V; Ermani M; DE Lotto F; Luisetto G
Ann N Y Acad Sci; 2007 Nov; 1117():357-61. PubMed ID: 17646261
[TBL] [Abstract][Full Text] [Related]
17. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
18. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism.
Beyer TD; Solorzano CC; Prinz RA; Babu A; Nilubol N; Patel S
Surgery; 2007 Jun; 141(6):777-83. PubMed ID: 17560254
[TBL] [Abstract][Full Text] [Related]
19. Postparathyroidectomy hypocalcemia as an accurate indicator of preparathyroidectomy bone histology in the uremic patient.
Felsenfeld AJ; Gutman RA; Llach F; Harrelson JM; Wells SA
Miner Electrolyte Metab; 1984; 10(3):166-72. PubMed ID: 6727802
[TBL] [Abstract][Full Text] [Related]
20. Teriparatide efficacy in the treatment of severe hypocalcemia after kidney transplantation in parathyroidectomized patients: a series of five case reports.
Nogueira EL; Costa AC; Santana A; Guerra JO; Silva S; Mil-Homens C; Costa AG
Transplantation; 2011 Aug; 92(3):316-20. PubMed ID: 21694663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
